Temperatures outside Nomura bank in London climbed into the high summertime registers as six biotech executives in dark suits filed into windowless rooms. The men were immediately segregated into two groups and told they had two days to turn a university spin-out into a billion dollar public company. Oh, and the two groups were competing against each other in a biotech "wargame," and would be observed and analyzed by industry experts.












